为您找到相关结果约500个

你是不是要搜索 期刊GLP-1 RA联合SGLT-2I治疗 点击跳转

SGLT-2 Inhibitors and GLP-1-RA reduce Risk of NAFLD in Type-2-Diabetes

GLP-1, SGLT-2, new devices for interventional cardiologists

GLP-1 receptor agonists in comparison with SGLT-2 inhibitors

Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute

Differentiated Use of SGLT-2-Inhibitors and GLP-1-Receptor Agonists

Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials Perspective on GLP-1 RA and SGLT-2i therapies

Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes

Mortality Differences SGLT-2, DPP-4 Inhibitors and GLP-1 Receptor Agonists

Cardiovascular outcomes with GLP-1 receptor agonists vs.SGLT-2 inhibitors in patients with type 2 diabetes

SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease

Choosing GLP-1 receptor agonists or SGLT-2 inhibitors by cardiorenal risk

Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists

SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline

Will GLP-1 Analogues and SGLT-2 Inhibitors Become New Game Changers for Diabetic Retinopathy?

Impact of GLP-1 receptor agonists versus SGLT-2 inhibitors on diabetic retinopathy

为您找到相关结果约500个

共500条页码: 1/34页15条/页